TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Merck Life Science AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
865,417
|
883,906
|
675,676 |
| Financial expenses |
0
|
819
|
22 |
| Earnings before taxes |
470,773
|
475,135
|
448,792 |
| EBITDA |
444,779
|
472,667
|
448,735 |
| Total assets |
964,627
|
613,179
|
419,610 |
| Current assets |
955,333
|
603,301
|
364,597 |
| Current liabilities |
64,406
|
88,958
|
49,047 |
| Equity capital |
892,974
|
516,998
|
366,188 |
| - share capital |
6,918
|
6,883
|
7,489 |
| Employees (average) |
48
|
46
|
29 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
92.6%
|
84.3%
|
87.3% |
| Turnover per employee |
18,030
|
19,215
|
23,299 |
| Profit as a percentage of turnover |
54.4%
|
53.8%
|
66.4% |
| Return on assets (ROA) |
48.8%
|
77.6%
|
107.0% |
| Current ratio |
1483.3%
|
678.2%
|
743.4% |
| Return on equity (ROE) |
52.7%
|
91.9%
|
122.6% |
| Change turnover |
-23,041
|
262,960
|
133,168 |
| Change turnover % |
-3%
|
42%
|
25% |
| Chg. No. of employees |
2
|
17
|
0 |
| Chg. No. of employees % |
4%
|
59%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.